Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$398,135,283
+$54,453,092 QoQ
Shares Held
3,512,132
-3.8% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#12
of 849 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. INCY ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
This page
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,135,283 | 3,512,132 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $343,682,191 | 3,651,532 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $392,939,851 | 3,978,332 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $384,030,874 | 4,528,132 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $264,359,569 | 3,881,932 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $224,563,722 | 3,708,732 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $282,215,323 | 4,085,932 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $297,419,594 | 4,499,540 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $316,335,588 | 5,218,337 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $323,386,615 | 5,676,437 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $348,731,704 | 5,553,937 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $277,095,711 | 4,796,533 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $300,554,765 | 4,828,189 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $404,887,832 | 5,602,433 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $366,920,474 | 4,568,233 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $323,019,607 | 4,847,233 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $390,693,426 | 5,142,733 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $373,086,012 | 4,697,633 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $336,959,802 | 4,590,733 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $303,404,605 | 4,411,233 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $379,858,139 | 4,515,133 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $398,120,030 | 4,898,733 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $512,236,788 | 5,889,133 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $556,868,109 | 6,205,350 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $652,032,259 | 6,271,350 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $337,023,499 | 4,602,260 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||